Life Science REIT (LON:LABS) Stock Price Down 0.5% – What’s Next?

Life Science REIT plc (LON:LABS)’s stock price traded down 0.5% during mid-day trading on Tuesday . The stock traded as low as GBX 36.70 ($0.46) and last traded at GBX 36.70 ($0.46). 321,672 shares were traded during trading, a decline of 21% from the average session volume of 409,043 shares. The stock had previously closed at GBX 36.90 ($0.46).

Analyst Ratings Changes

Several analysts have weighed in on LABS shares. Shore Capital reissued a “buy” rating on shares of Life Science REIT in a report on Thursday, September 26th. Berenberg Bank restated a “buy” rating and issued a GBX 57 ($0.71) price target on shares of Life Science REIT in a research report on Thursday, October 3rd.

Life Science REIT Price Performance

The stock has a market capitalization of £128.45 million, a price-to-earnings ratio of -611.67 and a beta of 0.08. The firm has a 50-day moving average of GBX 39.32 and a 200 day moving average of GBX 36.58.

About Life Science REIT

Life Science REIT plc (the Company) is a closed-ended Real Estate Investment Trust (REIT) incorporated in England and Wales on 27 July 2021. The Company began trading on 19 November 2021 and its shares are admitted to trading on the Premium Listing Segment of the Main Market of the London Stock Exchange.